WS #14738

Global markets are undergoing a severe stress test as the 10-year Treasury yield spikes to 5.17%, the highest level since 2007, driven by a combination of hawkish Fed rhetoric, persistent inflation data, and geopolitical risk premiums. This bond market selloff is acting as a powerful headwind for equities, causing US stocks to slip and pressuring duration-sensitive assets. The macro backdrop is being exacerbated by escalating Middle East tensions, where Houthi attacks on Saudi Aramco and French military commitments to protect Yanbu have kept Brent crude oil elevated near $107-108, further fueling inflationary pressures and consumer anxiety. Amidst this macro turbulence, specific sector narratives are diverging. The technology sector is showing signs of strain, with Meta rallying to near record highs on the back of its new AI hardware launch, while broader sentiment turns cautious as analysts flag record-high AI capex spending relative to GDP. In the energy sector, the geopolitical premium is clear, with oil majors benefiting from supply risks, though this creates a negative carry trade for airlines and shipping. Meanwhile, the pharmaceutical sector received a targeted positive catalyst with the FDA approval of Merck's new kidney cancer combination therapy, providing a bright spot for the healthcare index.